ICAM-1 levels in patients with covid-19 with diabetic foot ulcers: A prospective study in southeast asia.

ABSTRACT:

Background

Viral infection can compound the severity of pre-existing inflammation caused by underlying diseases. For those with a chronic, immune-related condition such as diabetic foot ulcers (DFUs), the coronavirus disease (COVID-19) serves to exacerbate the inflammatory burden. Serum levels of intracellular adhesion molecule-1 (ICAM-1), a primary mediator of cell adhesion express in the inflammatory process, are often used to indicate the gravity of all inflammatory conditions. Therefore, the purpose of this study was to investigate serum ICAM-1 levels before and after debridement in patients with DFUs who were also diagnosed as COVID-19 positive compared with those who were COVID-19 negative.

Methods

20 patients with DFUs were screened for COVID-19 and then divided into

SUBMITTER: Oley MH 

PROVIDER: S-EPMC7873613 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature